Wuyi International Pharmaceutical Co. Ltd. delayed the release of its 2016 financial report and asked that its shares be suspended from trading until the results are announced.

The audited results were due March 31 but will be postponed since the company requires more time and resources to prepare them and to resolve the requests raised by its auditor Crowe Horwath (HK) CPA Ltd.

Given the delay, Wuyi International is also moving its annual meeting to a date yet to be determined.